Certara’s SVP & Head of Quantitative Systems Pharmacology, Dr. Piet van der Graaf, discusses how biosimulation with Certara’s COVID-19 vaccine model can help optimize allocation of the world’s limited supplies of COVID-19 vaccines.
Leveraging Biosimulation to Inform Optimal Use of COVID-19 Vaccines
Feb 03, 2021